| EPB121 | Bictegravir-containing ART regimens and weight gain in children with perinatal HIV | E-poster | Weight gain |
| EPB122 | Non-invasive identification of severe NAFLD and risk stratification of clinical outcomes using Fibroscan-AST (FAST) score in 1683 people with HIV | E-poster | Hepatic complications (e.g., NASH) |
| EPB123 | Incidence and disease severity of non-alcoholic fatty liver disease among people living with HIV in Thailand | E-poster | Hepatic complications (e.g., NASH) |
| EPB124 | Low incidence of adverse drug reactions associated with generic-equivalent antiretroviral product substitutions in a publicly-funded HIV treatment program | E-poster | Other ART complications and adverse reactions |
| EPB125 | Switching to dual drug HIV regimen is associated with macrophage activation on a 2-years follow-up | E-poster | Other ART complications and adverse reactions |
| EPB126 | Incidental anaemia in patients started on antiretroviral therapy in Harare, Zimbabwe: a retrospective cohort study | E-poster | Other ART complications and adverse reactions |
| EPB127 | Platelet reactivity and activation in people living with HIV | E-poster | Other ART complications and adverse reactions |
| EPB128 | Impact of differentiated service delivery models on retention and viral load suppression among ART clients in Katakwi Destrict | E-poster | Other ART complications and adverse reactions |
| EPB129 | Pharmacotherapeutic profile, polypharmacy and its associated factors in a cohort of people living with HIV in Rio de Janeiro, Brazil | E-poster | Polypharmacy |
| EPB130 | Associations of frailty with cardiovascular disease risks in older people living with HIV | E-poster | Frailty |